Ben Jonson's Sejanus: historiography and the political tragedy

Though Ben Jonson's Sejanus has received virtually no approbation as a work for the theater, it has yet been the subject of much critical attention. There is widespread recognition that the play is no ordinary failure, that it is a work full of learning, carefully structured and thematically potent, an intelligent effort to reform Renaissance historical tragedy. Still there is no agreement about what kind of achievement the play actually represents. The concern of this dissertation is with the intellectual origins of the play; it is a study in the traditions and methods which appear to have guided Jonson in his writing of Sejanus. It is my thesis that its genesis is to be found in Jonson's interest in non-literary discipines - history, methods of historical writing, politics and constitutional issues - rather than in literary criticism and conventions. Jonson found his new style in political history, his themes in the conflict between morality and the logistics of realpolitik

Gastrointestinal tract size, total-tract digestibility, and rumen microflora in different dairy cow genotypes

peer-reviewedThe superior milk production efficiency of Jersey (JE) and Jersey × Holstein-Friesian (JE × HF) cows compared with Holstein-Friesian (HF) has been widely published. The biological differences among dairy cow genotypes, which could contribute to the milk production efficiency differences, have not been as widely studied however. A series of component studies were conducted using cows sourced from a longer-term genotype comparison study (JE, JE × HF, and HF). The objectives were to (1) determine if differences exist among genotypes regarding gastrointestinal tract (GIT) weight, (2) assess and quantify whether the genotypes tested differ in their ability to digest perennial ryegrass, and (3) examine the relative abundance of specific rumen microbial populations potentially relating to feed digestibility. Over 3 yr, the GIT weight was obtained from 33 HF, 35 JE, and 27 JE × HF nonlactating cows postslaughter. During the dry period the cows were offered a perennial ryegrass silage diet at maintenance level. The unadjusted GIT weight was heavier for the HF than for JE and JE × HF. When expressed as a proportion of body weight (BW), JE and JE × HF had a heavier GIT weight than HF. In vivo digestibility was evaluated on 16 each of JE, JE × HF, and HF lactating dairy cows. Cows were individually stalled, allowing for the total collection of feces and were offered freshly cut grass twice daily. During this time, daily milk yield, BW, and dry matter intake (DMI) were greater for HF and JE × HF than for JE; milk fat and protein concentration ranked oppositely. Daily milk solids yield did not differ among the 3 genotypes. Intake capacity, expressed as DMI per BW, tended to be different among treatments, with JE having the greatest DMI per BW, HF the lowest, and JE × HF being intermediate. Production efficiency, expressed as milk solids per DMI, was higher for JE than HF and JE × HF. Digestive efficiency, expressed as digestibility of dry matter, organic matter, N, neutral detergent fiber, and acid detergent fiber, was higher for JE than HF. In grazing cows (n = 15 per genotype) samples of rumen fluid, collected using a transesophageal sampling device, were analyzed to determine the relative abundance of rumen microbial populations of cellulolytic bacteria, protozoa, and fungi. These are critically important for fermentation of feed into short-chain fatty acids. A decrease was observed in the relative abundance of Ruminococcus flavefaciens in the JE rumen compared with HF and JE × HF. We can deduce from this study that the JE genotype has greater digestibility and a different rumen microbial population than HF. Jersey and JE × HF cows had a proportionally greater GIT weight than HF. These differences are likely to contribute to the production efficiency differences among genotypes previously reported

Glucocorticoid with cyclophosphamide for paraquat-induced lung fibrosis.

Paraquat is an effective and widely used herbicide but is also a lethal poison. In many developing countries paraquat is widely available and inexpensive, making poisoning prevention difficult. However most of the people who become poisoned from paraquat have taken it as a means of suicide.Standard treatment for paraquat poisoning both prevents further absorption and reduces the load of paraquat in the blood through haemoperfusion or haemodialysis. The effectiveness of standard treatments is extremely limited.The immune system plays an important role in exacerbating paraquat-induced lung fibrosis. Immunosuppressive treatment using glucocorticoid and cyclophosphamide in combination is being developed and studied. To assess the effects of glucocorticoid with cyclophosphamide on mortality in patients with paraquat-induced lung fibrosis. The most recent search was run on the 15th April 2014. We searched the Cochrane Injuries Group's Specialised Register, The Cochrane Library, Ovid MEDLINE(R), Ovid MEDLINE(R) In-Process & Other Non-Indexed Citations, Ovid MEDLINE(R) Daily and Ovid OLDMEDLINE(R), Embase Classic+Embase (Ovid), ISI WOS (SCI-EXPANDED, SSCI, CPCI-S & CPSI-SSH), trials registries, Chinese databases (, , ) and reference lists. RCTs were included in this review. All patients were to receive standard care, plus the intervention or control. The intervention was glucocorticoid with cyclophosphamide in combination versus a control of a placebo, standard care alone or any other therapy in addition to standard care. The mortality risk ratio (RR) and 95% confidence interval (CI) was calculated for each study on an intention-to-treat basis. Data for all-cause mortality at final follow-up were summarised in a meta-analysis using a fixed-effect model. This systematic review includes three trials with a combined total of 164 participants who had moderate to severe paraquat poisoning. Patients who received glucocorticoid with cyclophosphamide in addition to standard care had a lower risk of death at final follow-up than those receiving standard care only (RR 0.72; 95% CI 0.59 to 0.89). Based on the findings of three small RCTs of moderate to severely poisoned patients, glucocorticoid with cyclophosphamide in addition to standard care may be a beneficial treatment for patients with paraquat-induced lung fibrosis. To enable further study of the effects of glucocorticoid with cyclophosphamide for patients with moderate to severe paraquat poisoning, hospitals may provide this treatment as part of an RCT with allocation concealment

Integrated metabolome and transcriptome analysis of the NCI60 dataset

Abstract Background Metabolite profiles can be used for identifying molecular signatures and mechanisms underlying diseases since they reflect the outcome of complex upstream genomic, transcriptomic, proteomic and environmental events. The scarcity of publicly accessible large scale metabolome datasets related to human disease has been a major obstacle for assessing the potential of metabolites as biomarkers as well as understanding the molecular events underlying disease-related metabolic changes. The availability of metabolite and gene expression profiles for the NCI-60 cell lines offers the possibility of identifying significant metabolome and transcriptome features and discovering unique molecular processes related to different cancer types. Methods We utilized a combination of analytical methods in the R statistical package to evaluate metabolic features associated with cancer cell lines from different tissue origins, identify metabolite-gene correlations and detect outliers cell lines based on metabolome and transcriptome data. Statistical analysis results are integrated with metabolic pathway annotations as well as COSMIC and Tumorscape databases to explore associated molecular mechanisms. Results Our analysis reveals that although the NCI-60 metabolome dataset is quite noisy comparing with microarray-based transcriptome data, it does contain tissue origin specific signatures. We also identified biologically meaningful gene-metabolite associations. Most remarkably, several abnormal gene-metabolite relationships identified by our approach can be directly linked to known gene mutations and copy number variations in the corresponding cell lines. Conclusions Our results suggest that integrative metabolome and transcriptome analysis is a powerful method for understanding molecular machinery underlying various pathophysiological processes. We expect the availability of large scale metabolome data in the coming years will significantly promote the discovery of novel biomarkers, which will in turn improve the understanding of molecular mechanism underlying diseases.http://deepblue.lib.umich.edu/bitstream/2027.42/112946/1/12859_2011_Article_4394.pd

Comparison of routes for achieving parenteral access with a focus on the management of patients with Ebola virus disease.

Dehydration is an important cause of death in patients with Ebola virus disease (EVD). Parenteral fluids are often required in patients with fluid requirements in excess of their oral intake. The peripheral intravenous route is the most commonly used method of parenteral access, but inserting and maintaining an intravenous line can be challenging in the context of EVD. Therefore it is important to consider the advantages and disadvantages of different routes for achieving parenteral access (e.g. intravenous, intraosseous, subcutaneous and intraperitoneal). To compare the reliability, ease of use and speed of insertion of different parenteral access methods. We ran the search on 17 November 2014. We searched the Cochrane Injuries Group's Specialised Register, Cochrane Central Register of Controlled Trials (CENTRAL, The Cochrane Library), Ovid MEDLINE(R) In-Process & Other Non-Indexed Citations, Ovid MEDLINE(R) Daily, Ovid MEDLINE(R) and Ovid OLDMEDLINE(R), Embase Classic + Embase (OvidSP), CINAHL (EBSCOhost), clinicaltrials.gov and screened reference lists. Randomised controlled trials comparing different parenteral routes for the infusion of fluids or medication. Two review authors examined the titles and abstracts of records obtained by searching the electronic databases to determine eligibility. Two review authors extracted data from the included trials and assessed the risk of bias. Outcome measures of interest were success of insertion; time required for insertion; number of insertion attempts; number of dislodgements; time period with functional access; local site reactions; clinicians' perception of ease of administration; needlestick injury to healthcare workers; patients' discomfort; and mortality. For trials involving the administration of fluids we also collected data on the volume of fluid infused, changes in serum electrolytes and markers of renal function. We rated the quality of the evidence as 'high', 'moderate', 'low' or 'very low' according to the GRADE approach for the following outcomes: success of insertion, time required for insertion, number of dislodgements, volume of fluid infused and needlestick injuries. We included 17 trials involving 885 participants. Parenteral access was used to infuse fluids in 11 trials and medications in six trials. None of the trials involved patients with EVD. Intravenous and intraosseous access was compared in four trials; intravenous and subcutaneous access in 11; peripheral intravenous and intraperitoneal access in one; saphenous vein cutdown and intraosseous access in one; and intraperitoneal with subcutaneous access in one. All of the trials assessing the intravenous method involved peripheral intravenous access.We judged few trials to be at low risk of bias for any of the assessed domains.Compared to the intraosseous group, patients in the intravenous group were more likely to experience an insertion failure (risk ratio (RR) 3.89, 95% confidence interval (CI) 2.39 to 6.33; n = 242; GRADE rating: low). We did not pool data for time to insertion but estimates from the trials suggest that inserting intravenous access takes longer (GRADE rating: moderate). Clinicians judged the intravenous route to be easier to insert (RR 0.15, 95% CI 0.04 to 0.61; n = 182). A larger volume of fluids was infused via the intravenous route (GRADE rating: moderate). There was no evidence of a difference between the two routes for any other outcomes, including adverse events.Compared to the subcutaneous group, patients in the intravenous group were more likely to experience an insertion failure (RR 14.79, 95% CI 2.87 to 76.08; n = 238; GRADE rating: moderate) and dislodgement of the device (RR 3.78, 95% CI 1.16 to 12.34; n = 67; GRADE rating: low). Clinicians also judged the intravenous route as being more difficult to insert and patients were more likely to be agitated in the intravenous group. Patients in the intravenous group were more likely to develop a local infection and phlebitis, but were less likely to develop erythema, oedema or swelling than those in the subcutaneous group. A larger volume of fluids was infused into patients via the intravenous route. There was no evidence of a difference between the two routes for any other outcome.There were insufficient data to reliably determine if the risk of insertion failure differed between the saphenous vein cutdown (SVC) and intraosseous method (RR 4.00, 95% CI 0.51 to 31.13; GRADE rating: low). Insertion using SVC took longer than the intraosseous method (MD 219.60 seconds, 95% CI 135.44 to 303.76; GRADE rating: moderate). There were no data and therefore there was no evidence of a difference between the two routes for any other outcome.There were insufficient data to reliably determine the relative effects of intraperitoneal or central intravenous access relative to any other parenteral access method. There are several different ways of achieving parenteral access in patients who are unable meet their fluid requirements with oral intake alone. The quality of the evidence, as assessed using the GRADE criteria, is somewhat limited because of the lack of adequately powered trials at low risk of bias. However, we believe that there is sufficient evidence to draw the following conclusions: if peripheral intravenous access can be achieved easily, this allows infusion of larger volumes of fluid than other routes; but if this is not possible, the intraosseous and subcutaneous routes are viable alternatives. The subcutaneous route may be suitable for patients who are not severely dehydrated but in whom ongoing fluid losses cannot be met by oral intake.A film to accompany this review can be viewed here (http://youtu.be/ArVPzkf93ng)

Rate-dependent effect of amphetamine in rats: Extension to between-subjects effect

Following either variable-interval or fixed-interval training, 20 rats received both 0.5 and 2.0 mg/kg of amphetamine. For both schedules, amphetamine decreased response rates of high-rate subjects and increased those of low-rate subjects. Within-subject analysis of fixed-interval rates revealed the same rate-dependent effect. It is suggested that the between-subject and within-subject effects may have the same basis.Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/46393/1/213_2004_Article_BF00421119.pd

Registration of ‘Hallam’ Wheat

‘Hallam’ (Reg. no. CV-983, PI 638790) is a hard red winter wheat (Triticum aestivum L.) cultivar developed cooperatively by the Nebraska Agricultural Experiment Station and the USDA-ARS and released in 2005 by the developing institutions. Hallam was released primarily for its superior adaptation to rainfed wheat production systems in eastern Nebraska. The name Hallam was chosen to honor Hallam, NE, a town and its people rebuilding after a tornado. Hallam was selected from the cross ‘Brule’ (Schmidt et al., 1983)/‘Bennett’ (Schmidt et al., 1981)//‘Niobrara’ (Baenziger et al., 1996) that was made in 1992. The F1 generation was grown in the greenhouse and the F2 to F3 generations were advanced using the bulk breeding method in the field at Mead, NE. In 1995, single F3:4 rows were planted for selection. Hallam was selected in the F4 and there was no further selection thereafter. Hallam was evaluated as NE98471 in Nebraska yield nurseries starting in 1999, in the Northern Regional Performance Nursery in 2001 and 2002, and in Nebraska cultivar performance trials from 2002 to 2004. In the Nebraska cultivar performance trials, it was narrowly adapted and performs best in eastern Nebraska. The average Nebraska rainfed yield of Hallam of 4110 kg ha-1 (41 environments from 2002 to 2004) was greater than the yields of ‘Wahoo’ (4030 kg ha-1; Baenziger et al., 2002), ‘Alliance’ (3880 kg ha-1; Baenziger et al., 1995), and ‘Harry’ (4000 kg ha-1; Baenziger et al., 2004b), but was lower than ‘Millennium’ (4180 kg ha-1; Baenziger et al., 2001) and ‘Wesley’ (4210 kg ha-1; Peterson et al., 2001). In its primary area of adaptation (eastern Nebraska), Hallam has yielded 4540 kg ha-1 (five environments), which was greater than Wesley (4150 kg ha-1), Millennium (4250 kg ha-1), Wahoo (3940 kg ha-1), and Alliance (3900 kg ha21). In the Northern Regional Performance Nursery, Hallam ranked 14th of 30 in 2001 (12 environments) and fourth of 25 entries in 2002 (13 environments) and averaged 100 kg ha-1 more grain yield than ‘Nekota’ (Haley et al., 1996). Hallam is not recommended for use in irrigated production systems where other wheat cultivars with superior performance, especially with better straw strength (described below), would be recommended. Other measurements of performance from comparison trials show that Hallam is moderately early in maturity (142 d after January 1, five environments), about 2.5 d and 1.2 d earlier flowering than Millennium and Wesley, respectively. Hallam is a semidwarf wheat cultivar. Hallam has a medium short coleoptile (46 mm), as expected for a semidwarf wheat cultivar, and is shorter than ‘Goodstreak’ (61 mm; Baenziger et al., 2004a) and slightly longer than semidwarf wheat cultivars such as Harry (36 mm). The mature plant height of Hallam (86 cm) is 3 cm shorter than Millennium and 6 cm taller than Wesley (41 environments). Hallam has moderate straw strength (45% lodged), similar to Wahoo (46% lodged), but worse than Wesley (34% lodged) in those environments (3) where severe lodging was found. The winter hardiness of Hallamis good to very good, similar to ‘Abilene’ (PI 511307) and comparable to other winter wheat cultivars adapted and commonly grown in Nebraska

Registration of ‘Hallam’ Wheat

‘Hallam’ (Reg. no. CV-983, PI 638790) is a hard red winter wheat (Triticum aestivum L.) cultivar developed cooperatively by the Nebraska Agricultural Experiment Station and the USDA-ARS and released in 2005 by the developing institutions. Hallam was released primarily for its superior adaptation to rainfed wheat production systems in eastern Nebraska. The name Hallam was chosen to honor Hallam, NE, a town and its people rebuilding after a tornado. Hallam was selected from the cross ‘Brule’ (Schmidt et al., 1983)/‘Bennett’ (Schmidt et al., 1981)//‘Niobrara’ (Baenziger et al., 1996) that was made in 1992. The F1 generation was grown in the greenhouse and the F2 to F3 generations were advanced using the bulk breeding method in the field at Mead, NE. In 1995, single F3:4 rows were planted for selection. Hallam was selected in the F4 and there was no further selection thereafter. Hallam was evaluated as NE98471 in Nebraska yield nurseries starting in 1999, in the Northern Regional Performance Nursery in 2001 and 2002, and in Nebraska cultivar performance trials from 2002 to 2004. In the Nebraska cultivar performance trials, it was narrowly adapted and performs best in eastern Nebraska. The average Nebraska rainfed yield of Hallam of 4110 kg ha-1 (41 environments from 2002 to 2004) was greater than the yields of ‘Wahoo’ (4030 kg ha-1; Baenziger et al., 2002), ‘Alliance’ (3880 kg ha-1; Baenziger et al., 1995), and ‘Harry’ (4000 kg ha-1; Baenziger et al., 2004b), but was lower than ‘Millennium’ (4180 kg ha-1; Baenziger et al., 2001) and ‘Wesley’ (4210 kg ha-1; Peterson et al., 2001). In its primary area of adaptation (eastern Nebraska), Hallam has yielded 4540 kg ha-1 (five environments), which was greater than Wesley (4150 kg ha-1), Millennium (4250 kg ha-1), Wahoo (3940 kg ha-1), and Alliance (3900 kg ha21). In the Northern Regional Performance Nursery, Hallam ranked 14th of 30 in 2001 (12 environments) and fourth of 25 entries in 2002 (13 environments) and averaged 100 kg ha-1 more grain yield than ‘Nekota’ (Haley et al., 1996). Hallam is not recommended for use in irrigated production systems where other wheat cultivars with superior performance, especially with better straw strength (described below), would be recommended. Other measurements of performance from comparison trials show that Hallam is moderately early in maturity (142 d after January 1, five environments), about 2.5 d and 1.2 d earlier flowering than Millennium and Wesley, respectively. Hallam is a semidwarf wheat cultivar. Hallam has a medium short coleoptile (46 mm), as expected for a semidwarf wheat cultivar, and is shorter than ‘Goodstreak’ (61 mm; Baenziger et al., 2004a) and slightly longer than semidwarf wheat cultivars such as Harry (36 mm). The mature plant height of Hallam (86 cm) is 3 cm shorter than Millennium and 6 cm taller than Wesley (41 environments). Hallam has moderate straw strength (45% lodged), similar to Wahoo (46% lodged), but worse than Wesley (34% lodged) in those environments (3) where severe lodging was found. The winter hardiness of Hallamis good to very good, similar to ‘Abilene’ (PI 511307) and comparable to other winter wheat cultivars adapted and commonly grown in Nebraska